| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cannabis | 24 | 2026 | 79 | 11.650 |
Why?
|
| Marijuana Use | 9 | 2025 | 32 | 5.010 |
Why?
|
| Smoking | 19 | 2022 | 373 | 4.360 |
Why?
|
| Alcohol Drinking | 14 | 2025 | 298 | 3.710 |
Why?
|
| Pregnancy | 32 | 2026 | 1555 | 3.650 |
Why?
|
| Hallucinogens | 6 | 2022 | 21 | 3.630 |
Why?
|
| Prenatal Care | 12 | 2025 | 123 | 3.470 |
Why?
|
| Substance-Related Disorders | 12 | 2025 | 305 | 3.320 |
Why?
|
| Electronic Nicotine Delivery Systems | 10 | 2022 | 27 | 3.280 |
Why?
|
| Female | 82 | 2026 | 12193 | 3.080 |
Why?
|
| Humans | 97 | 2026 | 16832 | 2.960 |
Why?
|
| Pregnant Women | 7 | 2022 | 41 | 2.940 |
Why?
|
| Marijuana Smoking | 6 | 2024 | 40 | 2.750 |
Why?
|
| Adult | 58 | 2025 | 7255 | 2.530 |
Why?
|
| Pregnancy Complications | 5 | 2025 | 202 | 2.410 |
Why?
|
| Intimate Partner Violence | 4 | 2023 | 11 | 2.330 |
Why?
|
| Vaping | 7 | 2024 | 18 | 2.280 |
Why?
|
| California | 27 | 2026 | 2244 | 2.230 |
Why?
|
| Marijuana Abuse | 5 | 2021 | 33 | 2.030 |
Why?
|
| Nicotine | 5 | 2025 | 25 | 1.940 |
Why?
|
| Mental Disorders | 11 | 2020 | 248 | 1.870 |
Why?
|
| Self Report | 10 | 2025 | 248 | 1.820 |
Why?
|
| Smoking Cessation | 12 | 2020 | 140 | 1.750 |
Why?
|
| Legislation, Drug | 3 | 2024 | 10 | 1.670 |
Why?
|
| Young Adult | 25 | 2025 | 2456 | 1.500 |
Why?
|
| Delivery of Health Care, Integrated | 7 | 2021 | 515 | 1.420 |
Why?
|
| Cross-Sectional Studies | 16 | 2026 | 1233 | 1.380 |
Why?
|
| Adolescent | 23 | 2025 | 3464 | 1.350 |
Why?
|
| Tobacco Products | 4 | 2021 | 13 | 1.280 |
Why?
|
| Male | 46 | 2026 | 9556 | 1.250 |
Why?
|
| Public Health | 4 | 2022 | 80 | 1.230 |
Why?
|
| Prevalence | 11 | 2025 | 785 | 1.150 |
Why?
|
| Tobacco Use Disorder | 4 | 2017 | 32 | 1.130 |
Why?
|
| Smoke-Free Policy | 4 | 2017 | 6 | 1.080 |
Why?
|
| Middle Aged | 33 | 2024 | 7515 | 1.060 |
Why?
|
| Alcoholism | 6 | 2017 | 235 | 1.040 |
Why?
|
| Crime Victims | 3 | 2018 | 25 | 1.020 |
Why?
|
| Breast Feeding | 4 | 2021 | 112 | 0.990 |
Why?
|
| Life Change Events | 3 | 2018 | 26 | 0.990 |
Why?
|
| Commerce | 1 | 2026 | 37 | 0.940 |
Why?
|
| Counseling | 4 | 2020 | 170 | 0.930 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2020 | 353 | 0.910 |
Why?
|
| Resilience, Psychological | 1 | 2025 | 12 | 0.900 |
Why?
|
| Delivery of Health Care | 8 | 2022 | 374 | 0.900 |
Why?
|
| Mental Health | 3 | 2022 | 161 | 0.890 |
Why?
|
| United States | 20 | 2022 | 3858 | 0.890 |
Why?
|
| Hearing Loss | 1 | 2025 | 14 | 0.860 |
Why?
|
| Risk Factors | 14 | 2026 | 3108 | 0.830 |
Why?
|
| Medical Marijuana | 2 | 2021 | 21 | 0.820 |
Why?
|
| Retrospective Studies | 12 | 2026 | 2463 | 0.810 |
Why?
|
| Tobacco Smoking | 2 | 2021 | 16 | 0.800 |
Why?
|
| Anxiety Disorders | 3 | 2022 | 96 | 0.780 |
Why?
|
| HIV Infections | 4 | 2021 | 708 | 0.760 |
Why?
|
| Methamphetamine | 1 | 2022 | 3 | 0.760 |
Why?
|
| Cocaine | 1 | 2022 | 6 | 0.750 |
Why?
|
| Qualitative Research | 1 | 2024 | 288 | 0.750 |
Why?
|
| Electronic Health Records | 6 | 2024 | 702 | 0.740 |
Why?
|
| Surveys and Questionnaires | 12 | 2022 | 1204 | 0.730 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2025 | 206 | 0.720 |
Why?
|
| Patient Protection and Affordable Care Act | 6 | 2020 | 41 | 0.710 |
Why?
|
| Child | 10 | 2022 | 2433 | 0.710 |
Why?
|
| Alcohol-Related Disorders | 2 | 2012 | 36 | 0.680 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2012 | 6 | 0.680 |
Why?
|
| Documentation | 2 | 2020 | 37 | 0.670 |
Why?
|
| Mass Screening | 4 | 2020 | 670 | 0.660 |
Why?
|
| Insurance Coverage | 3 | 2020 | 102 | 0.650 |
Why?
|
| Anxiety | 3 | 2022 | 154 | 0.650 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2022 | 158 | 0.640 |
Why?
|
| Stress, Psychological | 5 | 2022 | 136 | 0.630 |
Why?
|
| Opioid-Related Disorders | 3 | 2017 | 174 | 0.630 |
Why?
|
| Twins, Monozygotic | 3 | 2015 | 10 | 0.630 |
Why?
|
| Spouse Abuse | 2 | 2017 | 8 | 0.620 |
Why?
|
| Consultants | 1 | 2019 | 1 | 0.620 |
Why?
|
| Smoking Prevention | 2 | 2017 | 32 | 0.610 |
Why?
|
| Postnatal Care | 1 | 2019 | 20 | 0.610 |
Why?
|
| Drug Administration Routes | 1 | 2019 | 4 | 0.610 |
Why?
|
| Health Policy | 2 | 2018 | 101 | 0.600 |
Why?
|
| Pandemics | 6 | 2023 | 289 | 0.580 |
Why?
|
| Patient Participation | 2 | 2020 | 120 | 0.580 |
Why?
|
| Aged | 14 | 2024 | 5901 | 0.570 |
Why?
|
| Mothers | 1 | 2019 | 104 | 0.570 |
Why?
|
| Longitudinal Studies | 11 | 2020 | 653 | 0.570 |
Why?
|
| Cannabinoid Receptor Agonists | 3 | 2022 | 8 | 0.560 |
Why?
|
| Sex Offenses | 1 | 2018 | 9 | 0.560 |
Why?
|
| Health Personnel | 1 | 2020 | 132 | 0.560 |
Why?
|
| Depression | 4 | 2022 | 479 | 0.550 |
Why?
|
| Depressive Disorder | 1 | 2020 | 177 | 0.550 |
Why?
|
| Adult Survivors of Child Adverse Events | 1 | 2018 | 4 | 0.540 |
Why?
|
| Twins, Dizygotic | 2 | 2015 | 7 | 0.520 |
Why?
|
| Child Abuse | 2 | 2026 | 44 | 0.520 |
Why?
|
| Tobacco Use Cessation | 1 | 2017 | 16 | 0.510 |
Why?
|
| Medicaid | 2 | 2018 | 189 | 0.490 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2014 | 70 | 0.490 |
Why?
|
| Health Communication | 1 | 2016 | 16 | 0.480 |
Why?
|
| Professional-Patient Relations | 1 | 2016 | 45 | 0.470 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 39 | 0.470 |
Why?
|
| Socioeconomic Factors | 5 | 2024 | 571 | 0.460 |
Why?
|
| Social Environment | 3 | 2015 | 77 | 0.450 |
Why?
|
| Underage Drinking | 1 | 2015 | 6 | 0.440 |
Why?
|
| Social Behavior | 1 | 2015 | 20 | 0.440 |
Why?
|
| Depressive Disorder, Major | 3 | 2013 | 95 | 0.440 |
Why?
|
| Attitude | 1 | 2015 | 27 | 0.440 |
Why?
|
| Motivation | 4 | 2015 | 103 | 0.430 |
Why?
|
| Menthol | 1 | 2014 | 1 | 0.430 |
Why?
|
| Prisons | 1 | 2015 | 28 | 0.430 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 239 | 0.420 |
Why?
|
| Diseases in Twins | 3 | 2013 | 15 | 0.420 |
Why?
|
| Analgesics | 3 | 2022 | 25 | 0.410 |
Why?
|
| Adaptation, Psychological | 2 | 2022 | 76 | 0.400 |
Why?
|
| Preconception Care | 2 | 2025 | 43 | 0.390 |
Why?
|
| Cannabinoids | 2 | 2024 | 6 | 0.390 |
Why?
|
| Taxes | 1 | 2013 | 23 | 0.390 |
Why?
|
| Health Resources | 1 | 2013 | 35 | 0.380 |
Why?
|
| Health Surveys | 1 | 2013 | 226 | 0.370 |
Why?
|
| Stress, Physiological | 1 | 2012 | 3 | 0.370 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 268 | 0.360 |
Why?
|
| Logistic Models | 5 | 2021 | 796 | 0.340 |
Why?
|
| San Francisco | 4 | 2015 | 54 | 0.340 |
Why?
|
| Vitamins | 2 | 2022 | 56 | 0.340 |
Why?
|
| Ethanol | 2 | 2022 | 19 | 0.340 |
Why?
|
| Attitude of Health Personnel | 2 | 2024 | 197 | 0.320 |
Why?
|
| Postpartum Period | 2 | 2021 | 89 | 0.320 |
Why?
|
| Sex Factors | 4 | 2017 | 560 | 0.320 |
Why?
|
| Lactation | 2 | 2021 | 37 | 0.310 |
Why?
|
| Infant, Newborn | 2 | 2025 | 828 | 0.310 |
Why?
|
| Tobacco Use | 2 | 2020 | 12 | 0.300 |
Why?
|
| Women's Health | 2 | 2022 | 178 | 0.290 |
Why?
|
| Affect | 1 | 2009 | 21 | 0.290 |
Why?
|
| Reproductive History | 1 | 2017 | 13 | 0.270 |
Why?
|
| Breast Diseases | 1 | 2017 | 11 | 0.270 |
Why?
|
| Calcinosis | 1 | 2017 | 18 | 0.270 |
Why?
|
| Breast | 1 | 2017 | 66 | 0.260 |
Why?
|
| Metabolic Syndrome | 1 | 2007 | 59 | 0.250 |
Why?
|
| Postmenopause | 1 | 2017 | 243 | 0.240 |
Why?
|
| Mammography | 1 | 2017 | 141 | 0.240 |
Why?
|
| Sexual Partners | 2 | 2019 | 34 | 0.240 |
Why?
|
| Conjunctival Diseases | 1 | 2026 | 1 | 0.240 |
Why?
|
| Eye Hemorrhage | 1 | 2026 | 1 | 0.240 |
Why?
|
| Age of Onset | 4 | 2015 | 66 | 0.240 |
Why?
|
| Pregnancy Trimester, First | 1 | 2025 | 45 | 0.220 |
Why?
|
| Vomiting | 1 | 2024 | 11 | 0.210 |
Why?
|
| Infant | 2 | 2026 | 1212 | 0.210 |
Why?
|
| Social Norms | 1 | 2024 | 2 | 0.210 |
Why?
|
| Age Factors | 4 | 2014 | 814 | 0.210 |
Why?
|
| Health Services Accessibility | 4 | 2020 | 262 | 0.200 |
Why?
|
| Educational Status | 3 | 2020 | 163 | 0.200 |
Why?
|
| Adolescent Behavior | 1 | 2024 | 118 | 0.190 |
Why?
|
| Prospective Studies | 3 | 2022 | 1186 | 0.190 |
Why?
|
| Comorbidity | 4 | 2020 | 516 | 0.190 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 520 | 0.190 |
Why?
|
| Industry | 1 | 2022 | 1 | 0.180 |
Why?
|
| Drug and Narcotic Control | 1 | 2022 | 4 | 0.180 |
Why?
|
| Virginia | 2 | 2012 | 4 | 0.180 |
Why?
|
| Motivational Interviewing | 1 | 2022 | 29 | 0.180 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2022 | 53 | 0.180 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 22 | 0.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 352 | 0.170 |
Why?
|
| Cannabidiol | 1 | 2021 | 1 | 0.170 |
Why?
|
| Pilot Projects | 2 | 2019 | 210 | 0.170 |
Why?
|
| Social Media | 1 | 2021 | 11 | 0.170 |
Why?
|
| Pregnancy, Unwanted | 1 | 2020 | 7 | 0.160 |
Why?
|
| Family | 2 | 2019 | 99 | 0.160 |
Why?
|
| Psychotic Disorders | 1 | 2021 | 52 | 0.160 |
Why?
|
| Intention | 1 | 2020 | 28 | 0.160 |
Why?
|
| Workload | 1 | 2020 | 26 | 0.160 |
Why?
|
| Self Medication | 1 | 2020 | 5 | 0.160 |
Why?
|
| Psychological Trauma | 1 | 2020 | 6 | 0.160 |
Why?
|
| International Agencies | 1 | 2019 | 1 | 0.160 |
Why?
|
| Obstetrics | 1 | 2020 | 20 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 49 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 56 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2024 | 2396 | 0.150 |
Why?
|
| Skin Cream | 1 | 2019 | 2 | 0.150 |
Why?
|
| Mentally Ill Persons | 2 | 2016 | 3 | 0.150 |
Why?
|
| Plants, Edible | 1 | 2019 | 5 | 0.150 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 185 | 0.150 |
Why?
|
| Palliative Care | 1 | 2020 | 53 | 0.150 |
Why?
|
| Suicide | 1 | 2020 | 114 | 0.150 |
Why?
|
| Regression Analysis | 2 | 2017 | 261 | 0.140 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 1887 | 0.140 |
Why?
|
| Meaningful Use | 1 | 2018 | 4 | 0.140 |
Why?
|
| Emergency Service, Hospital | 2 | 2024 | 393 | 0.140 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 169 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2020 | 147 | 0.140 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 489 | 0.140 |
Why?
|
| Primary Health Care | 2 | 2021 | 693 | 0.130 |
Why?
|
| Substance Abuse Detection | 1 | 2017 | 16 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2018 | 108 | 0.130 |
Why?
|
| Patient Admission | 1 | 2017 | 58 | 0.130 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2014 | 21 | 0.120 |
Why?
|
| Health Services Needs and Demand | 1 | 2017 | 84 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 325 | 0.120 |
Why?
|
| Natural Language Processing | 1 | 2017 | 60 | 0.120 |
Why?
|
| Buprenorphine | 1 | 2017 | 50 | 0.120 |
Why?
|
| Quality of Life | 1 | 2019 | 477 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 213 | 0.120 |
Why?
|
| Cooking | 1 | 2015 | 17 | 0.120 |
Why?
|
| Nutritional Sciences | 1 | 2015 | 9 | 0.120 |
Why?
|
| Meals | 1 | 2015 | 7 | 0.120 |
Why?
|
| Time Factors | 1 | 2018 | 989 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 445 | 0.110 |
Why?
|
| Twins | 2 | 2012 | 11 | 0.110 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 7 | 0.110 |
Why?
|
| Residence Characteristics | 2 | 2014 | 244 | 0.110 |
Why?
|
| Multilevel Analysis | 1 | 2015 | 11 | 0.110 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2015 | 12 | 0.110 |
Why?
|
| Gender Identity | 1 | 2015 | 33 | 0.110 |
Why?
|
| Environment | 1 | 2015 | 47 | 0.110 |
Why?
|
| Hypertension | 1 | 2019 | 475 | 0.110 |
Why?
|
| Feeding Behavior | 1 | 2015 | 161 | 0.110 |
Why?
|
| Severity of Illness Index | 5 | 2015 | 410 | 0.110 |
Why?
|
| Decision Making | 1 | 2016 | 164 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 187 | 0.110 |
Why?
|
| Cancer Survivors | 1 | 2016 | 114 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2016 | 184 | 0.110 |
Why?
|
| Sex | 1 | 2014 | 2 | 0.110 |
Why?
|
| Internet | 1 | 2015 | 207 | 0.100 |
Why?
|
| Restaurants | 1 | 2014 | 17 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 677 | 0.100 |
Why?
|
| Vocabulary | 1 | 2013 | 1 | 0.100 |
Why?
|
| Minority Groups | 1 | 2014 | 99 | 0.100 |
Why?
|
| Memory | 1 | 2013 | 13 | 0.100 |
Why?
|
| Attention | 1 | 2013 | 11 | 0.100 |
Why?
|
| Cotinine | 1 | 2013 | 6 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 290 | 0.100 |
Why?
|
| Risk-Taking | 1 | 2014 | 92 | 0.100 |
Why?
|
| Interpersonal Relations | 1 | 2013 | 38 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2010 | 100 | 0.100 |
Why?
|
| Quinoxalines | 1 | 2012 | 11 | 0.090 |
Why?
|
| Nicotinic Agonists | 1 | 2012 | 15 | 0.090 |
Why?
|
| Benzazepines | 1 | 2012 | 24 | 0.090 |
Why?
|
| Environmental Exposure | 1 | 2013 | 120 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2012 | 58 | 0.090 |
Why?
|
| Twin Studies as Topic | 1 | 2011 | 3 | 0.080 |
Why?
|
| Genetics, Behavioral | 1 | 2011 | 1 | 0.080 |
Why?
|
| Schizotypal Personality Disorder | 1 | 2011 | 2 | 0.080 |
Why?
|
| Genotype | 1 | 2011 | 198 | 0.080 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 553 | 0.080 |
Why?
|
| Antisocial Personality Disorder | 1 | 2010 | 2 | 0.080 |
Why?
|
| Registries | 1 | 2012 | 449 | 0.080 |
Why?
|
| Child Abuse, Sexual | 1 | 2010 | 13 | 0.080 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2009 | 17 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 319 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2010 | 569 | 0.070 |
Why?
|
| Arteries | 1 | 2017 | 7 | 0.070 |
Why?
|
| Sweden | 1 | 2007 | 17 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 291 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2007 | 191 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 79 | 0.060 |
Why?
|
| Health Behavior | 2 | 2018 | 332 | 0.050 |
Why?
|
| Income | 2 | 2013 | 81 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2026 | 1430 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 229 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 7 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 568 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 8 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 35 | 0.040 |
Why?
|
| Psychometrics | 1 | 2020 | 114 | 0.040 |
Why?
|
| Continuity of Patient Care | 1 | 2021 | 94 | 0.040 |
Why?
|
| Focus Groups | 1 | 2020 | 140 | 0.040 |
Why?
|
| Pain | 1 | 2020 | 65 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2020 | 121 | 0.040 |
Why?
|
| Alcoholic Intoxication | 1 | 2017 | 5 | 0.030 |
Why?
|
| Binge Drinking | 1 | 2017 | 8 | 0.030 |
Why?
|
| Opiate Substitution Treatment | 1 | 2017 | 53 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 1047 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2015 | 32 | 0.030 |
Why?
|
| Transdermal Patch | 1 | 2015 | 1 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 995 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 447 | 0.030 |
Why?
|
| Adolescent Health Services | 1 | 2015 | 36 | 0.030 |
Why?
|
| Set (Psychology) | 1 | 2013 | 1 | 0.030 |
Why?
|
| Automobiles | 1 | 2013 | 2 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 47 | 0.020 |
Why?
|
| Arousal | 1 | 2013 | 4 | 0.020 |
Why?
|
| Mental Recall | 1 | 2013 | 27 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2015 | 132 | 0.020 |
Why?
|
| Housing | 1 | 2013 | 38 | 0.020 |
Why?
|
| Varenicline | 1 | 2012 | 12 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2013 | 71 | 0.020 |
Why?
|
| Poverty | 1 | 2013 | 167 | 0.020 |
Why?
|
| Population | 1 | 2011 | 3 | 0.020 |
Why?
|
| Marital Status | 1 | 2011 | 17 | 0.020 |
Why?
|
| Personality | 1 | 2011 | 6 | 0.020 |
Why?
|
| Triplets | 1 | 2011 | 2 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2011 | 21 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 105 | 0.020 |
Why?
|
| Los Angeles | 1 | 2011 | 139 | 0.020 |
Why?
|
| Northern Ireland | 1 | 2010 | 1 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2010 | 11 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2010 | 38 | 0.020 |
Why?
|
| Siblings | 1 | 2010 | 12 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 20 | 0.020 |
Why?
|
| Ethnic Groups | 1 | 2011 | 418 | 0.020 |
Why?
|